Literature DB >> 10899376

Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice.

Z Li1, C F Wu, G Pei, Y Y Guo, X Li.   

Abstract

The antagonistic effect of pseudoginoside-F11 (PF(11)) on the various actions of morphine was studied in mice. The results demonstrated that PF(11), at the doses of 4 and 8 mg/kg, PO, significantly inhibited morphine (10 mg/kg, SC)-induced memory impairment in the Morris water maze test. PF(11), at 4 mg/kg, PO, did not influence conditioned place preference per se, yet markedly blocked the conditioned place preference to morphine. PF(11), at the doses of 4 and 8 mg/kg, PO, also significantly antagonized morphine (5 mg/kg, SC)-induced analgesia tested by tail pinch method. PF(11), at 4 mg/kg, PO, did not influence locomotor activity per se, yet inhibited the development of the reverse tolerance, as shown by the increase in locomotor activity, to morphine. At the doses of 4 and 8 mg/kg, PO, PF(11) significantly antagonized the development of analgesia tolerance to morphine in the tail pinch test. Thus, the above results demonstrate for the first time that PF(11) can antagonize some actions of morphine. However, the mechanism of action of PF(11) merits further evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899376     DOI: 10.1016/s0091-3057(00)00260-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?

Authors:  Jeanine Ward; Christopher Rosenbaum; Christina Hernon; Christopher R McCurdy; Edward W Boyer
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

2.  Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.

Authors:  Yue-Yang Liu; Tian-Yu Zhang; Xue Xue; Dong-Mei Liu; Hao-Tian Zhang; Lin-Lin Yuan; Ying-Lu Liu; Han-Lin Yang; Shi-Bo Sun; Cheng Zhang; He-Song Xu; Chun-Fu Wu; Jing-Yu Yang
Journal:  CNS Neurosci Ther       Date:  2017-05-09       Impact factor: 5.243

3.  Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.

Authors:  Kequan Fu; Huiyang Lin; Yoshiaki Miyamoto; Chunfu Wu; Jingyu Yang; Kyosuke Uno; Atsumi Nitta
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

Review 4.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Pseudoginsenoside F11, a Novel Partial PPAR γ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes.

Authors:  Guoyu Wu; Junyang Yi; Ling Liu; Pengcheng Wang; Zhijie Zhang; Zhen Li
Journal:  PPAR Res       Date:  2013-12-18       Impact factor: 4.964

6.  Neuroprotective effect of pseudoginsenoside-f11 on a rat model of Parkinson's disease induced by 6-hydroxydopamine.

Authors:  Jian Yu Wang; Jing Yu Yang; Fang Wang; Shi Yuan Fu; Yue Hou; Bo Jiang; Jie Ma; Cui Song; Chun Fu Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-10       Impact factor: 2.629

Review 7.  Discovery, semisynthesis, biological activities, and metabolism of ocotillol-type saponins.

Authors:  Juan Liu; Yangrong Xu; Jingjing Yang; Wenzhi Wang; Jianqiang Zhang; Renmei Zhang; Qingguo Meng
Journal:  J Ginseng Res       Date:  2017-01-13       Impact factor: 6.060

Review 8.  Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study.

Authors:  Md Jakaria; Md Ezazul Haque; Joonsoo Kim; Duk-Yeon Cho; In-Su Kim; Dong-Kug Choi
Journal:  Oncotarget       Date:  2018-09-11

Review 9.  Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis.

Authors:  Yiwei Zeng; Yunhui Chen; Su Zhang; Huan Ren; Jialin Xia; Mengnan Liu; Baozhi Shan; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.